Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Cipla Limited
CIPLACipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India. Address: Cipla House, Mumbai, India, 400013
Analytics
Objectif de Cours de WallStreet
123 445.22 INRRatio C/B
28.3376Rendement du dividende
0.83 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés CIPLA
Analyse des dividendes CIPLA
Croissance des dividendes sur 5 ans
183 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
16 %Historique des dividendes CIPLA
Valorisation des titres CIPLA
financières CIPLA
Résultats | 2019 | Dynamique |